K-numberK242411
Device nameBrainomix 360 e-Lung
ApplicantBrainomix Limited
Product codeJAK
Device classClass II
Decision dateFeb 19, 2025
DecisionSubstantially Equivalent
Regulation892.1750
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

Brainomix 360 e-Lung is a software package that analyzes CT chest scans to provide quantitative measurements of lung tissue, including 3D segmentation, volumetric measurements, and density evaluations. It is intended as a workflow enhancement tool to support physicians in examining pulmonary and thoracic tissue and documenting radiological findings that may indicate chest disease.

Technological characteristics

The proposed device uses an AI/ML image processing algorithm for lung segmentation (versus the predicate's non-AI approach), adds a longitudinal assessment feature that automatically groups and compares scans from the same patient, and outputs results to PACS and cloud platforms (versus the predicate's web UI only). Minor UI improvements include adjustable slab thickness, original resolution viewing, and dynamic MPR with cross hair.

Test standards cited

DICOM (Digital Imaging and Communications in Medicine) compliance per NEMA PS 3.1–3.20; ISO 14971:2019 for risk management; FDA Cybersecurity Guidance and IEC 81001-5-1 for cybersecurity; 21 CFR Part 820.30 design controls. Validation included head-to-head comparison of lung segmentation accuracy using Dice Similarity Coefficient (DSC) against a ground-truth consensus mask from three board-certified radiologists.

Substantial equivalence argument

Both devices perform the same intended function—quantitative CT analysis of lung tissue using Hounsfield Units to distinguish tissue types, with identical indications for use, product code (JAK), intended 2D comparative review, and reporting capabilities. Although the proposed device improves the segmentation algorithm with AI/ML (demonstrating higher DSC values) and adds longitudinal assessment and PACS/cloud output features, these enhancements do not raise different safety or effectiveness questions because they automate and improve existing capabilities without changing the fundamental principles of operation or expanding the scope of use.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →